Help us spread the word about the benefits of treatment for anxiety and mood disorders, OCD, and PTSD — for children and teens, women, college students, military and military families.
Please tweet, post on Facebook, or add the links to your own website — whatever works to get the word out that you are not alone and help is here!
Bradley C. Riemann, PhD (Clinical Director, OCD Center & CBT Services at Rogers Memorial Hospital) and Thröstur Björgvinsson, PhD (Program Director, Houston OCD Program) answered our questions.
Instead of letting her depression run her life, she decided to outrun it.
“I have clinical depression,” says Mara Suttman-Lea. “No, I am not depressed. I suffer from depression. They are two vastly different concepts.”
This study is testing to see what behavior and brain function can tell us about treatment success in depression using cognitive-behavioral therapy, a standard psychotherapy treatment for depressive disorders.
The study purpose is to evaluate what brain function can tell us about treatment success in anxiety disorders.
Time commitment is about 33 hours over 22 visits.
Volunteers will participate in the following:
18 to 25 years old
Suffering from depression
18 to 55 years old
Suffering from an anxiety disorder
Volunteers may not have metal in their body.
6 CE or CME
Ticketed event (includes lunch):
Robin Williams and too many others have lost their lives to suicide. Williams' tragic death made highly public the great need for increased awareness of the grave risk that suicide poses.
The purpose of the current study is to evaluate the efficacy of d-cycloserine in augmenting treatment of smoking cessation for individuals with panic attacks. Individuals will receive 7 weeks of panic- and smoking-reduction treatment (PSRT) and one pill of d-cycloserine (DCS) or one pill placebo one hour prior to sessions 3, 4, and 5 (i.e., 3 single doses). Participants will also be given nicotine replacement therapy as part of PSRT (i.e., the patch).